What is NDC 68084-850?

68084-850 is the product NDC for Potassium Citrate, Potassium citrate 10 meq/1 tablet, extended release, listed with the FDA by American Health Packaging. It has 1 package NDC, shown above in 10- and 11-digit form.

American Health Packaging, NDC labeler code 68084. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Potassium Citrate?

37 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Potassium Citrate NDC 68084-850 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)68084-850Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68084-0850Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68084-850-32	6808408503268084085032	20 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-850-32) / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (68084-850-33)Marketed from Nov 12, 2014

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Potassium Citrate
Generic name (nonproprietary): potassium citrate
Active ingredients: Potassium citrate — 10 meq/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: American Health PackagingNDC labeler code 68084
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 203546
Marketing start: Nov 12, 2014
Listing expires: Dec 31, 2026
Other FDA classes: Acidifying Activity (Mechanism)Calcium Chelating Activity (Mechanism)Decreased Coagulation Factor Activity (Physiologic effect)
Identifiers: Product ID 68084-850_213c9f49-5d37-f84f-e063-6394a90aa698SPL ID 213c9f49-5d37-f84f-e063-6394a90aa698SPL set ID 1201c777-2388-4235-bb8f-eb7dc1e867f8RxCUI 199381UNII EE90ONI6FF
Pharmacologic class: Anti-coagulant; Calculi Dissolution Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468084085032 followed by a unit qualifier and the quantity

Package 68084-0850-32. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 3, 2024.

Indications (excerpt from the label)

Potassium citrate extended-release tablet is a citrate salt of potassium indicated for the management of: Renal tubular acidosis (RTA) with calcium stones (1.1) Hypocitraturic calcium oxalate nephrolithiasis of any etiology (1.2) Uric acid lithiasis with or without calcium stones (1.3) 1.1 Renal Tubular Acidosis (RTA) with Calcium Stones Potassium citrate is indicated for the management of renal tubular acidosis [see Clinical Studies (14.1) ]. 1.2 Hypocitraturic Calcium Oxalate Nephrolithiasis of any Etiology Potassium citrate is indicated for the management of Hypocitraturic calcium oxalate nephrolithiasis [see Clinical Studies (14.2) ]. 1.3 Uric Acid Lithiasis with or without Calcium Stone…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 68084-850

What is NDC 68084-850?: 68084-850 is the product NDC for Potassium Citrate, Potassium citrate 10 meq/1 tablet, extended release, listed with the FDA by American Health Packaging. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Potassium Citrate.
What is the active ingredient?: Potassium citrate.
Who is the labeler?: American Health Packaging, NDC labeler code 68084. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Potassium Citrate?: 37 other product NDCs are listed under this name. See all Potassium Citrate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Potassium Citrate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Potassium Citrate	Potassium citrate 10 meq/1	Tablet, Extended releaseOral	REMEDYREPACK INC.	70518-4477	70518-4477-00
Potassium Citrate	Potassium citrate 540 mg/1	Tablet, Extended releaseOral	Rising Pharma Holdings, Inc.	16571-864	16571-0864-01
Potassium Citrate	Potassium citrate 1080 mg/1	Tablet, Extended releaseOral	Rising Pharma Holdings, Inc.	16571-865	16571-0865-01
Potassium Citrate	Potassium citrate 10 meq/1	TabletOral	Biocomp Pharma, Inc.	44523-410	44523-0410-01
Potassium Citrate	Potassium citrate 10 meq/1	Tablet, Extended releaseOral	REMEDYREPACK INC.	70518-3160	70518-3160-00
Potassium Citrate	Potassium citrate 5 meq/1	Tablet, Extended releaseOral	XLCare Pharmaceuticals, Inc.	72865-191	72865-0191-01
Potassium Citrate	Potassium citrate 5 meq/1	Tablet, Extended releaseOral	Camber Pharmaceuticals, Inc	31722-129	31722-0129-01
Potassium Citrate	Potassium citrate 10 meq/1	Tablet, Extended releaseOral	Camber Pharmaceuticals, Inc	31722-130	31722-0130-01
Potassium Citrate	Potassium citrate 15 meq/1	Tablet, Extended releaseOral	Camber Pharmaceuticals, Inc	31722-132	31722-0132-01
Potassium Citrate	Potassium citrate 15 meq/1	Tablet, Extended releaseOral	Bryant Ranch Prepack	71335-2897	71335-2897-01

All 38 Potassium Citrate NDCs

Other NDCs under ANDA 203546

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 203546
Product	Strength	Form · route	Labeler	Product NDC
Potassium Citrate	Potassium citrate 5 meq/1	Tablet, Extended releaseOral	Golden State Medical Supply, Inc.	51407-449
Potassium Citrate	Potassium citrate 10 meq/1	Tablet, Extended releaseOral	Golden State Medical Supply, Inc.	51407-450
Potassium Citrate	Potassium citrate 15 meq/1	Tablet, Extended releaseOral	Golden State Medical Supply, Inc.	51407-451
Potassium Citrate	Potassium citrate 5 meq/1	Tablet, Extended releaseOral	Zydus Lifesciences Limited	65841-536
Potassium Citrate	Potassium citrate 10 meq/1	Tablet, Extended releaseOral	Zydus Lifesciences Limited	65841-537
Potassium Citrate	Potassium citrate 15 meq/1	Tablet, Extended releaseOral	Zydus Lifesciences Limited	65841-538
Potassium Citrate	Potassium citrate 5 meq/1	Tablet, Extended releaseOral	Zydus Pharmaceuticals (USA) Inc.	68382-536
Potassium Citrate	Potassium citrate 10 meq/1	Tablet, Extended releaseOral	Zydus Pharmaceuticals (USA) Inc.	68382-537
Potassium Citrate	Potassium citrate 15 meq/1	Tablet, Extended releaseOral	Zydus Pharmaceuticals (USA) Inc.	68382-538